Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

Abstract Introduction Atopic dermatitis (AD) can require long-term therapy. Few real-world studies have evaluated long-term effectiveness from the patients’ perspective. The aim of this study was to evaluate patient-reported outcomes (PROs) during long-term dupilumab treatment. Methods Adults with m...

Full description

Bibliographic Details
Main Authors: Alexa B. Kimball, Dimittri Delevry, Min Yang, Chien-Chia Chuang, Zhixiao Wang, Gaëlle Bégo-Le-Bagousse, Bruno Martins, Eric Wu, Brad Shumel, Jessie Wang, Debra Sierka, Jingdong Chao, Bruce Strober
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-08-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Disease control
Dupilumab
Health-related quality of life
Long-term treatment response
Patient-reported outcomes
Online Access:https://doi.org/10.1007/s13555-023-00965-5

Internet

https://doi.org/10.1007/s13555-023-00965-5

Similar Items